Definitive Healthcare (DH) Research & Development (2020 - 2026)

Definitive Healthcare's Research & Development history runs 7 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• Quarterly Research & Development fell 68.53% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.6 million (down 41.76% YoY) and the FY2025 annual result came in at $34.8 million, down 4.77% from the prior year.
• Research & Development was $6.5 million for Q1 2026 at Definitive Healthcare, up from -$26.7 million in the prior quarter.
• Across five years, Research & Development topped out at $24.7 million in Q2 2023 and bottomed at -$26.9 million in Q4 2024.
• A 5-year average of $13.2 million and a median of $20.5 million in 2025 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development surged 346.35% — and 2024, when it sank 332.66%.
• Definitive Healthcare's Research & Development stood at $10.1 million in 2022, then grew by 14.22% to $11.6 million in 2023, then sank by 332.66% to -$26.9 million in 2024, then increased by 0.71% to -$26.7 million in 2025, then soared by 124.32% to $6.5 million in 2026.
• Business Quant data shows DH's Research & Development at $6.5 million in Q1 2026, -$26.7 million in Q4 2025, and $20.4 million in Q3 2025.